InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Indivior Pharmaceuticals, Inc.

INDV Clue Score71
United States Fiscal year ends December CIK 0001625297
$35.83 +1.07% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $35.83 +1,102.35% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2021Revenue791.0Operating income213.0Net income205.0Fiscal year 2022Revenue901.0 +13.9%Operating income−81.0Net income−44.0 −121.5%EPS, diluted−0.32Fiscal year 2023Revenue1,093.0 +21.3%Operating income−152.0Net income−126.0EPS, diluted−0.92Fiscal year 2024Revenue1,188.0 +8.7%Operating income38.0Net income7.0EPS, diluted0.05Fiscal year 2025Revenue1,239.0 +4.3%Operating income262.0Net income210.0 +2,900.0%EPS, diluted1.64 +3,180.0%
FY2021FY2022FY2023FY2024FY2025
Revenue 791.0 901.0 1,093.0 1,188.0 1,239.0
Growth +13.9% +21.3% +8.7% +4.3%
Operating income 213.0 −81.0 −152.0 38.0 262.0
Net income 205.0 −44.0 −126.0 7.0 210.0
Growth −121.5% +2,900.0%
EPS, diluted n/a −0.32 −0.92 0.05 1.64
Growth +3,180.0%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2021Gross margin83.9%Operating margin26.9%Net margin25.9%Free cash flow margin44.1%Fiscal year 2022Gross margin82.4%Operating margin−9.0%Net margin−4.9%Free cash flow margin−1.0%Fiscal year 2023Gross margin83.0%Operating margin−13.9%Net margin−11.5%Free cash flow margin−28.2%Fiscal year 2024Operating margin3.2%Net margin0.6%Free cash flow margin0.6%Fiscal year 2025Operating margin21.1%Net margin16.9%Free cash flow margin−7.5%
FY2021FY2022FY2023FY2024FY2025
Gross margin 83.9% 82.4% 83.0% n/a n/a
Operating margin 26.9% −9.0% −13.9% 3.2% 21.1%
Net margin 25.9% −4.9% −11.5% 0.6% 16.9%
Free cash flow margin 44.1% −1.0% −28.2% 0.6% −7.5%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2021Operating cash flow353.0Capital expenditure−4.0Free cash flow349.0Buybacks−101.0Fiscal year 2022Operating cash flow−4.0Capital expenditure−5.0Free cash flow−9.0 −102.6%Buybacks−90.0Fiscal year 2023Operating cash flow−300.0Capital expenditure−8.0Free cash flow−308.0Buybacks−33.0Fiscal year 2024Operating cash flow36.0Capital expenditure−29.0Free cash flow7.0Buybacks−173.0Fiscal year 2025Operating cash flow−27.0Capital expenditure−66.0Free cash flow−93.0 −1,428.6%Buybacks−11.0
FY2021FY2022FY2023FY2024FY2025
Operating cash flow 353.0 −4.0 −300.0 36.0 −27.0
Capital expenditure −4.0 −5.0 −8.0 −29.0 −66.0
Free cash flow 349.0 −9.0 −308.0 7.0 −93.0
Growth −102.6% −1,428.6%
Buybacks −101.0 −90.0 −33.0 −173.0 −11.0

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2021Cash1,102.0Total debt239.0Net cash (debt)863.0Shareholders’ equity121.0Debt to equity1.98Fiscal year 2022Cash774.0Total debt237.0Net cash (debt)537.0Shareholders’ equity−15.0Fiscal year 2023Cash316.0Total debt240.0Net cash (debt)76.0Shareholders’ equity−184.0Fiscal year 2024Cash319.0Total debt333.0Net cash (debt)−14.0Shareholders’ equity−337.0Fiscal year 2025Cash195.0Total debt319.0Net cash (debt)−124.0Shareholders’ equity−98.0
FY2021FY2022FY2023FY2024FY2025
Cash 1,102.0 774.0 316.0 319.0 195.0
Total debt 239.0 237.0 240.0 333.0 319.0
Net cash (debt) 863.0 537.0 76.0 −14.0 −124.0
Shareholders’ equity 121.0 −15.0 −184.0 −337.0 −98.0
Debt to equity 1.98 n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
791.0 901.0 1,093.0 1,188.0 1,239.0
Growth +13.9% +21.3% +8.7% +4.3%
127.0 151.0 174.0 231.0 246.0
664.0 742.0 907.0 n/a n/a
Growth +11.7% +22.2%
52.0 72.0 106.0 n/a n/a
431.0 763.0 811.0 n/a n/a
213.0 −81.0 −152.0 38.0 262.0
Growth −138.0% +589.5%
190.0 −89.0 −145.0 20.0 239.0
−15.0 −44.0 −19.0 13.0 29.0
205.0 −44.0 −126.0 7.0 210.0
Growth −121.5% +2,900.0%
Per share
n/a −0.32 −0.92 0.05 1.68
n/a −0.32 −0.92 0.05 1.64
Growth +3,180.0%
145.7 139.0 137.0 132.0 125.0
151.9 139.0 137.0 133.0 128.0
Growth −8.5% −1.4% −2.9% −3.8%

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 2 of 5 years on file.